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This case report demonstrates that measurement of the
activity of technetium-99m-methylene diphosphonate in
bone can play an important role in the diagnosis and fol-
low-up of bone lesions in sickle-cell anaemia. In this case,
the whole-body scan revealed remarkably increased activity
in the spleen region, in the right ulna and in the left femoral
head, consistent with bone infarcts. Bone scanning is a reli-
able imaging method for early detection and diagnosis of
osseous and extraosseous crises in sickle-cell anaemia.
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ickle-cell disease is one of the most common chronic haemo-
lobinopathies in the world.1 It is highly prevalent in Africa
nd the Mediterranean region2,3 and is strongly associated
ith Plasmodium falciparum malaria.4,5
Technetium-99m-methylene diphosphonate (Tc-99m MDP)
one scintigraphy has been used to detect sickle-cell disease
nvolving the bones. Bone uptake varies in cases of bony in-
arcts, with decreasing activity due to vascular occlusion and
ncreasing uptake during the healing phase of bone
nfarction.6,7y, Faculty of Applied Medical Sciences, Taibah University, P.O. Box:
66 597883039; fax: +966 148475970.
td. All rights reserved.
Figure 1: Anterior and posterior whole body delayed images. 99m-TC MDP bone scan showed increasing activity at splenic region
(arrows) and an increasing uptake also noted in the right ulna, and left femoral head, consistent with bone infarcts (arrows).
S. Salih 79Although the high prevalence of malaria in central Sudan is
strongly associated with sickle-cell anaemia, the case reported
here was the first case of sickle-cell disease referred to the
Department of Nuclear Medicine, National Cancer Institute,
since it was established in 1995.
Case description
A 16-year-old girl with sickle-cell disease and complaining of
bone and joint pain was referred to our department for an
MDP bone scan, to rule out a skeletal or soft tissue crisis. Hae-
moglobin (Hb) analysis showed 72% Hb SS, 25% Hb F and
3% Hb A2.
Abone scanwas performed 3 h after intravenous administra-
tion of 444MBq of 99mTc MDP. The scan showed increasing
soft tissue uptake in the left upper quadrant, consistent with a
splenic infarct. Increased uptake was also seen in the right ulna
and left femoral head, consistent with bone infarcts. Uptake in
the acetabulum indicated a right hip infection (Figure 1).
Discussion
The finding of increased uptake in the right ulna and left femoral
head, consistent with bone infarcts, is supported by Lutzker and
Alavi6 and Sevim et al.7, who reported that 99mTcMDP uptake
in sickle-cell disease increases during the healing phase of bone
infarction. Increased uptake of 99mTc MDP was also seen in
the left upper quadrant, thought to be due to splenic infarction
and subsequent calcification. This result is also in accordance
with those of Lutzker and Alavi6, who reported uptake of
MDP by the spleen in sickle-cell disease during healing after
splenic infarction and subsequently as a result of calcification.
Uptake has also been reported, however, in some patients with
hyperparathyroidism, chronic renal failure8,9, breast cancer10,
neuroblastoma11 and myocardial infarction.12 Therefore, the
medical history of the patient should be clearly correlated with
the results of the bone scan finding.
The reason that no other cases of sickle-cell disease have
been reported previously to our department might be lack of
information among physicians about the benefit of nuclear
medicine investigations in cases of sickle-cell anaemia crises.
Conclusion
Bone scanning is a reliable imaging method, which can be used
for early detection of sickle-cell anaemia crises, particularly in
regions where there is a high prevalence of P. falciparum ma-
laria. Careful examination of the patient’s history and the dis-
tribution of MDP are mandatory for accurate diagnosis of
sickle-cell disease crises.
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